Advanced Malignant Solid Neoplasm Recruiting Phase 1 Trials for Sirolimus (DB00877)

IndicationStatusPhase
DBCOND0082736 (Advanced Malignant Solid Neoplasm)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02389309Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid TumorsTreatment